| Stage | LGIH | % of rev | JBI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $516M | 100.00% | $234M | 100.00% | LGIH ×2.21 |
| Gross profit | $102M | 19.71% | $80M | 34.39% | JBI +14.7pp |
| Operating income | $29M | 5.61% | $21M | 8.82% | JBI +3.2pp |
| Pre-tax income | $37M | 7.09% | $13M | 5.61% | LGIH +1.5pp |
| Net income | $27M | 5.23% | $11M | 4.58% | LGIH +0.6pp |
| Stage | LGIH | JBI | Gap · A − B |
|---|---|---|---|
| Revenue | $516M100.00% | $234M100.00% | LGIH ×2.21 |
| Gross profit | 19.71%$102M | 34.39%$80M | JBI +14.7pp |
| Operating income | 5.61%$29M | 8.82%$21M | JBI +3.2pp |
| Pre-tax income | 7.09%$37M | 5.61%$13M | LGIH +1.5pp |
| Net income |
| 5.23%$27M |
| 4.58%$11M |
| LGIH +0.6pp |
No disclosed counterparties: JBI.
None